Corimmun GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.corimmun.com
Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Pilot Study of COR-1 in Heart Failure
Phase 2
Completed
- Conditions
- Cardiomyopathy, Dilated
- Interventions
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2014-10-17
- Lead Sponsor
- Corimmun GmbH
- Target Recruit Count
- 36
- Registration Number
- NCT01391507
Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2013-04-08
- Lead Sponsor
- Corimmun GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT01043146
- Locations
- 🇩🇪
ABX-CRO, Goerlitz, Saxonia, Germany
News
No news found